Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility

Siegel, 2017, Cancer statistics, 2017, CA Cancer J Clin, 67, 7, 10.3322/caac.21387 Alberg, 2005, Epidemiology of lung cancer: looking to the future, J Clin Oncol, 23, 3175, 10.1200/JCO.2005.10.462 Goode, 2002, Polymorphisms in DNA repair genes and associations with cancer risk, Cancer Epidemiol Biomark Prev, 11, 1513 Wu, 2004, Genetic susceptibility to tobacco-related cancer, Oncogene, 23, 6500, 10.1038/sj.onc.1207811 Hung, 2008, A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25, Nature, 452, 633, 10.1038/nature06885 Cheng, 2017, Targeted sequencing of chromosome 15q25 identified novel variants associated with risk of lung cancer and smoking behavior in Chinese, Carcinogenesis, 38, 552, 10.1093/carcin/bgx025 Littman, 2004, Prior lung disease and risk of lung cancer in a large prospective study, Cancer Causes Control, 15, 819, 10.1023/B:CACO.0000043432.71626.45 Brown, 2005, Asthma and risk of death from lung cancer: NHANES II Mortality Study, J Asthma, 42, 597, 10.1080/02770900500216234 Ballaz, 2003, The potential contributions of chronic inflammation to lung carcinogenesis, Clin Lung Cancer, 5, 46, 10.3816/CLC.2003.n.021 Chen, 2003, Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer, Clin Cancer Res, 9, 729 Chen, 2005, Tumor-associated macrophages: the double-edged sword in cancer progression, J Clin Oncol, 23, 953, 10.1200/JCO.2005.12.172 Forrest, 2005, A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer, Br J Cancer, 92, 1834, 10.1038/sj.bjc.6602591 Moss, 2005, Mechanisms of disease: inflammation and the origins of cancer, Nat Clin Pract Oncol, 2, 90, 10.1038/ncponc0081 Bidwell, 2001, Cytokine gene polymorphism in human disease: on-line databases, supplement 1, Genes Immun, 2, 61, 10.1038/sj.gene.6363733 Haukim, 2002, Cytokine gene polymorphism in human disease: on-line databases, supplement 2, Genes Immun, 3, 313, 10.1038/sj.gene.6363881 El-Omar, 2003, Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms, Gastroenterology, 124, 1193, 10.1016/S0016-5085(03)00157-4 El-Omar, 2000, Interleukin-1 polymorphisms associated with increased risk of gastric cancer, Nature, 404, 398, 10.1038/35006081 Kamangar, 2006, Interleukin-1B polymorphisms and gastric cancer risk—a meta-analysis, Cancer Epidemiol Biomark Prev, 15, 1920, 10.1158/1055-9965.EPI-06-0267 Kupcinskas, 2010, Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis, Eur J Gastroenterol Hepatol, 22, 1189, 10.1097/MEG.0b013e32833cf3d5 Kim, 2014, Ethnic differences in gastric cancer genetic susceptibility: allele flips of interleukin gene, World J Gastroenterol, 20, 4558, 10.3748/wjg.v20.i16.4558 Liao, 2015, Association between Th17-related cytokines and risk of non-small cell lung cancer among patients with or without chronic obstructive pulmonary disease, Cancer, 121, 3122, 10.1002/cncr.29369 Li, 2015, IL1B gene polymorphisms, age and the risk of non-small cell lung cancer in a Chinese population, Lung Cancer, 89, 232, 10.1016/j.lungcan.2015.06.009 Landvik, 2009, A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer, Carcinogenesis, 30, 1186, 10.1093/carcin/bgp122 Landvik, 2012, Functional analysis of a lung cancer risk haplotype in the IL1B gene regulatory region, J Hum Genet, 57, 747, 10.1038/jhg.2012.106 Zienolddiny, 2004, Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer, Int J Cancer, 109, 353, 10.1002/ijc.11695 Lind, 2005, Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene, Lung Cancer, 50, 285, 10.1016/j.lungcan.2005.07.003 Champiat, 2014, Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC, J Thorac Oncol, 9, 144, 10.1097/JTO.0000000000000074 Goodman, 2004, The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements, J Natl Cancer Inst, 96, 1743, 10.1093/jnci/djh320 Sjöholm, 2007, Assessing quality and functionality of DNA from fresh and archival dried blood spots and recommendations for quality control guidelines, Clin Chem, 53, 1401, 10.1373/clinchem.2007.087510 Bergen, 2005, Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex whole genome amplified DNA generated from multiple DNA sources, Hum Mutat, 26, 262, 10.1002/humu.20213 Packer, 2006, SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes, Nucleic Acids Res, 34, D617, 10.1093/nar/gkj151 den Dunnen, 2001, Nomenclature for the description of human sequence variations, Hum Genet, 109, 121, 10.1007/s004390100505 Stephens, 2003, A comparison of bayesian methods for haplotype reconstruction from population genotype data, Am J Hum Genet, 73, 1162, 10.1086/379378 Bach, 2003, Variations in lung cancer risk among smokers, J Natl Cancer Inst, 95, 470, 10.1093/jnci/95.6.470 Campa, 2005, Lack of association between polymorphisms in inflammatory genes and lung cancer risk, Cancer Epidemiol Biomark Prev, 14, 538, 10.1158/1055-9965.EPI-04-0513 Shih, 2006, Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer, Lung Cancer, 52, 15, 10.1016/j.lungcan.2005.11.011 Kang, 2006, Polymorphisms in TGF-beta1 gene and the risk of lung cancer, Lung Cancer, 52, 1, 10.1016/j.lungcan.2005.11.016 Park, 2006, Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study, BMC Cancer, 6, 70, 10.1186/1471-2407-6-70 Kiyohara, 2010, IL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population, J Thorac Oncol, 5, 299, 10.1097/JTO.0b013e3181c8cae3 Lewis, 2006, Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment, J Transl Med, 4, 48, 10.1186/1479-5876-4-48 Lind, 2007, Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells, Cytokine, 38, 43, 10.1016/j.cyto.2007.05.001 Landvik, 2012, Molecular characterization of a cancer-related single nucleotide polymorphism in the pro-inflammatory interleukin-1B gene, Mol Carcinog, 51 Suppl 1, E168, 10.1002/mc.21910 Rogus, 2008, IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein, Hum Genet, 123, 387, 10.1007/s00439-008-0488-6 Dannenberg, 2005, Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention, J Clin Oncol, 23, 254, 10.1200/JCO.2005.09.112 Khuri, 2001, Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer, Clin Cancer Res, 7, 861 Campa, 2004, Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer, Carcinogenesis, 25, 229, 10.1093/carcin/bgh008 Seifart, 2005, TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer, Dis Markers, 21, 157, 10.1155/2005/707131 Lim, 2011, Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers, Carcinogenesis, 32, 522, 10.1093/carcin/bgr006 Bai, 2013, Genetic single-nucleotide polymorphisms of inflammation-related factors associated with risk of lung cancer, Med Oncol, 30, 414, 10.1007/s12032-012-0414-6 Ridker, 2017, Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial, Lancet, 390, 1833, 10.1016/S0140-6736(17)32247-X